• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall VITEK GPS106 Gram Positive Susceptibility Card

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall VITEK GPS106 Gram Positive Susceptibility Cardsee related information
Date Initiated by FirmJanuary 15, 2004
Date PostedJuly 20, 2004
Recall Status1 Terminated 3 on November 24, 2004
Recall NumberZ-0725-04
Recall Event ID 28429
Product Classification System, Test, Automated, Antimicrobial Susceptibility, Short Incubation - Product Code LON
ProductVITEK GPS-106 Gram Positive Susceptibility Card, Catalog #V4335, for in-vitro diagnostic use, 20 cards per package. The responsible firm on the label is bioMerieux, Inc., Durham, NC and bioMerieux sa, France.
Code Information Lot P61X, Exp. 5/12/05
Recalling Firm/
Manufacturer
bioMerieux Inc
595 Anglum Rd
Hazelwood MO 63042-2320
For Additional Information ContactNancy Weaver
314-731-8595
Manufacturer Reason
for Recall
The cards were stamped with an incorrect card code that causes the system to read and analyze the cards incorrectly.
FDA Determined
Cause 2
Other
ActionThe firm issued recall letters dated 1/15/04 via regular mail requesting remaining inventories be destroyed and explaining the method which the customer can use to confirm the cards were not misreported. The firm also issued a 'Second Notification' recall letter dated 3/9/04.
Quantity in Commerce1,955/20-card boxes
DistributionDistribution was nationwide to medical facilities, including V.A. and military customers. There was no foreign distribution.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-